Highest-materiality recent filing
CNO Financial 2026 annual meeting elects all nine director nominees; all proposals pass
All nine director nominees elected: Bhojwani, Brown, Foss, Gibson, Lee, Maurer, Ragavan, Shebik, Turner, each with >80M votes for.
CNO Q1 2026 net income $38M; operating EPS up 33% YoY to $1.05
Net income $38M ($0.39 diluted EPS) vs $21.5M ($0.21) YoY; net operating income $101M ($1.05) vs $81.1M ($0.79).
CNO declares $0.17 quarterly dividend; director Nina Henderson to retire at 2026 annual meeting
Quarterly dividend of $0.17 per share declared, payable March 24, 2026, to holders of record March 10, 2026.
CNO Financial Q4 net operating income $1.47/sh, up 12% YoY; FY2025 operating EPS $4.40
Q4 2025 net operating income of $143M ($1.47 diluted EPS), up 12% YoY; net income $93M ($0.95/sh).
CNO Financial appoints Linda Gibson to board; former PGIM Quantitative CEO
Linda Gibson appointed as independent director, effective January 15, 2026, expanding board to 10 members.
CNO Financial Q3 operating EPS $1.29, up 16%; sales up 26%; boosts ROE target
Net operating income $127.2M ($1.29/sh) vs $119.2M ($1.11) in 3Q24, up 7% and 16%.
CNO Financial Group provides Consumer Division briefing with key operating metrics
Employs ~3,400 associates, contracts with over 10,000 agents and partners.
CNO Financial Q2 net income $91.8M ($0.91 EPS), down 21% YoY; NAP up 17%
Net income of $91.8M ($0.91 diluted EPS) vs $116.3M ($1.06) in 2Q24; net operating income $87.5M ($0.87) vs $114.6M ($1.05).
CNO Financial Group updates investors on $37B portfolio; no material changes disclosed
Company employs 3,400 associates, works with 10,000 agents and independent partners.
CNO Financial amends credit facility, reduces rates, extends maturity to 2030
SOFR margins reduced to 1.125%-1.750%; commitment fee unchanged; letter of credit sublimit increased to $7.5M.
CNO Q1 GAAP net income drops to $0.13/shr; operating EPS up 52%, guidance reaffirmed
GAAP net income $13.7M ($0.13/diluted share) vs $112.3M ($1.01) in 1Q24, driven by non-economic market volatility impacts.
CNO Financial increases share repurchase authorization by $500M, declares $0.16 dividend
Board approved additional $500M for share repurchases; $240.3M remained as of Dec 31, 2024.
CNO Financial Q4 net income $166.1M ($1.58 EPS); operating EPS up 41% YoY ex items
Net income $166.1M ($1.58 diluted EPS) vs $36.3M ($0.32) in 4Q23; FY net income $404.0M ($3.74).
CNO Financial names Joel Koehneman as CAO, replacing Michellen Wildin
Joel Koehneman, age 39, appointed CAO effective January 21, 2025; reports to CFO Paul McDonough.
CNO Financial Q3 net operating income $1.11 EPS, up 26% YoY; raises full-year guidance
Net operating income of $1.11/dil share vs $0.88 YoY; GAAP net income $0.09 due to non-economic accounting impacts (market volatility, FIA embedded derivative changes).
CNO Financial appoints Jess Turner to board of directors effective Oct 1, 2024
Turner is EVP & Global Head of Open Banking & API at Mastercard (MA); brings fintech, digital product, and tech security expertise.
CNO Financial Q2 net income $116.3M ($1.06/diluted), up 66%; operating EPS $1.05, up 94%
Net income $116.3M ($1.06/diluted) vs $73.7M ($0.64) YoY, up 66%; operating income $114.6M ($1.05/diluted), up 94%.
CNO Financial issues $700M of 6.450% senior notes due 2034; proceeds to refinance 2025 notes
Issued $700M of 6.450% senior notes maturing June 15, 2034.
All 8 director nominees elected; David B. Foss received 81.1M for (lowest support) vs 16.4M against.
CNO Financial Q1 net income $112.3M ($1.01/diluted) vs loss a year ago; operating EPS flat
Net income $112.3M ($1.01/diluted) vs net loss $0.8M ($0.01 loss) in Q1 2023.
On October 1, 2024, the Board of Directors (the “Board”) of CNO Financial Group, Inc. (the “Company”) appointed Jessica A. Turner to serve as an independent director
Max materiality 0.85 · Median 0.62 · Most common event earnings